Intravascular lymphoma associated with haemophagocytic syndrome: A very rare entity in western countries

European Journal of Haematology

Volumn 75, Issue 4, 2005, Pages 341-345

  Terrier, Benjamin ^a   Aouba, Achille ^a,b   Vasiliu, Viorel ^a   Charlier, Caroline ^a   Delarue, Richard ^a   Buzyn, Agnès ^a   Hermine, Olivier ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Cochin Hospital ^*  (France)

Author keywords

Haemophagocytic syndrome; Intravascular lymphoma; Rituximab

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; BLEOMYCIN; DEXAMETHASONE; DOXORUBICIN; RITUXIMAB; VINDESINE;

ADULT; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER INFILTRATION; CASE REPORT; CAUCASIAN; DEATH; DISEASE ASSOCIATION; EARLY DIAGNOSIS; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; HUMAN TISSUE; INTRAVASCULAR LYMPHOMA; LIVER BIOPSY; LYMPHOCYTIC INFILTRATION; LYMPHOMA; PRIORITY JOURNAL; RARE DISEASE; REMISSION; SEPTIC SHOCK; WESTERN HEMISPHERE;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; LYMPHOMA; LYMPHOMA, LARGE-CELL, DIFFUSE; MIDDLE AGED; NEOPLASM INVASIVENESS; REMISSION INDUCTION; SHOCK, SEPTIC; VASCULAR NEOPLASMS; WESTERN WORLD;

EID: 24744441307     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00519.x     Document Type: Article

References (20)

1. FERRERI AJ, CAMPO E, SEYMOUR JF, et al. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the 'cutaneous variant'. Br J Haematol 2004;127:173-183.
2. MURASE T, NAKAMURA S. An Asian variant of intravascular lymphomatosis: an updated review of malignant histiocytosis-like B-cell lymphoma. Leuk Lymphoma 1999;33:459-473.
3. DIGIUSEPPE JA, NELSON WG, SEIFTER EJ, BOITNOTT JK, MANN RB. Intravascular lymphomatosis: a clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol. 1994;12:2573-2579.
4. HARRIS NL, JAFFE ES, DIEBOLD J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-3849.
5. KARRAS A, HERMINE O. Hemophagocytic syndrome. Rev Med Intern 2002;23:768-778.
6. WOLTER M, BADOUAL C, WECHSLER J, LAMBOLEZ T, HAIOUN C, BOULOC A, AUTHIER FJ, REVUZ J, BAGOT M. Intravascular large cell lymphoma revealed by diffuse telangiectasia and cauda equina syndrome. Ann Dermatol Venereol 2002;129:320-324.
7. DUFAU JP, LE TOURNEAU A, MOLINA T, et al. Intravascular large B-cell lymphoma with bone marrow involvement at presentation and haemophagocytic syndrome: two western cases in favour of a specific variant. Histopathology 2000;37:509-512.
8. BHAGWATI NS, OISETH SJ, ABEBE LS, WIERNIK PH. Intravascular lymphoma associated with hemophagocytic syndrome: a rare but aggressive clinical entity. Ann Hematol 2004;83:247-250.
9. ANGHEL G, PETRINATO G, SEVERING A, REMOTTI D, INSABATO L, DE RENZO A, ROTOLI B, MAJOLINO I. Intravascular B-cell lymphoma: report of two cases with different clinical presentation but rapid central nervous system involvement. Leuk Lymphoma 2003;44:1353-1359.
10. MURASE T, TASHIRO K, SUZUKI T, SAITO H, NAKAMURA S. Detection of antibodies to Fasciola and Anisakis in Japanese patients with intravascular lymphomatosis. Blood 1998;92:2182-2183.
11. SHIMAZAKI C, INABA T, NAKAGAWA M. B-cell lymphoma-associated hemophagocytic syndrome. Leuk Lymphoma 2000;38:121-130.
12. NARIMATSU H, MORISHITA Y, SAITO S, et al. Usefulness of bone marrow aspiration for definite diagnosis of Asian variant of intravascular lymphoma: four autopsied cases. Leuk Lymphoma 2004;45:1611-1616.
13. MIYAHARA M, SANO M, SHIBATA K, et al. B-cell lymphoma-associated hemophagocytic syndrome: clinicopathological characteristics. Ann Hematol 2000;79:378-388.
14. JALKANEN S, AHO R, KALLAJOKI M, et al. Lymphocyte homing receptors and adhesion molecules in intravascular malignant lymphomatosis. Int J Cancer 1989;44:777-782.
15. FERRY JA, HARRIS NL, PICKER LJ, et al. Intravascular lymphomatosis (malignant angioendotheliomatosis). A B-cell neoplasm expressing surface homing receptors. Mod Pathol 1988;1:444-452.
16. PONZONI M, ARRIGONI G, GOULD VE, et al. Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis. Hum Pathol 2000;31:220-226.
17. BOGOMOLSKI-YAHALOM V, Lossos IS, OKUN E, SHERMAN Y, LOSSOS A, POLLIACK A. Intravascular lymphomatosis - an indolent or aggressive entity? Leuk Lymphoma 1998;29:585-593.
18. KOIZUMI M, NISHIMURA M, YOKOTA A, MUNEKATA S, KOBAYASHI T, SAITO Y. Successful treatment of intravascular malignant lymphomatosis with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2001;27:1101-1103.
19. FERRERI AJ, CAMPO E, AMBROSETTI A, et al. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. Ann Oncol 2004;15:1215-1221.
20. HAN K, HALEY JC, CARLSON K, PINTER-BROWN L, SORIANO T. Regression of cutaneous intravascular lymphoma with rituximab. Cutis 2003;72:137-140.